100-49-2 | Cyclohexanemethanol

Packsize	Purity	Availability	Price	Discounted Price
10g	98%	in stock	$11.00	$8.00
25g	98%	in stock	$13.00	$9.00
100g	98%	in stock	$50.00	$35.00
500g	98%	in stock	$85.00	$60.00

Description

• Catalog Number: AA00022
• Chemical Name: Cyclohexanemethanol
• CAS Number: 100-49-2
• Molecular Formula: C7H14O
• Molecular Weight: 114.18545999999998
• MDL Number: MFCD00001510
• SMILES: OCC1CCCCC1
• NSC Number: 5288

Computed Properties

• Complexity: 55.4
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 8
• Hydrogen Bond Acceptor Count: 1
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 1
• XLogP3: 1.9

Upstream Synthesis Route

Cyclohexanemethanol, also known as benzyl alcohol, is a versatile compound widely used in chemical synthesis processes. With its unique chemical properties, cyclohexanemethanol serves as a valuable building block in the production of pharmaceuticals, fragrances, and polymers. In chemical synthesis, cyclohexanemethanol acts as a precursor for the synthesis of various esters, ethers, and carboxylic acids. It is frequently employed as a solvent in organic reactions due to its ability to dissolve a wide range of organic and inorganic substances. Additionally, cyclohexanemethanol plays a crucial role as a reducing agent in certain chemical transformations, contributing to the efficient and selective synthesis of desired products.

Literature

• Acceptorless photocatalytic dehydrogenation for alcohol decarbonylation and imine synthesis.

  Angewandte Chemie (International ed. in English) 20120820

• Synthesis and structure of the β-carboline derivatives and their binding intensity with cyclin-dependent kinase 2.

  Chemical & pharmaceutical bulletin 20120101

• Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors.

  Bioorganic & medicinal chemistry 20110101

• Design and synthesis of novel hydroxyalkylaminomethylchromones for their IL-5 inhibitory activity.

  Bioorganic & medicinal chemistry 20100701

• Synthesis and evaluation of novel chromone analogs for their inhibitory activity against interleukin-5.

  European journal of medicinal chemistry 20100601

• The role of alkoxy group on the A ring of isoflavones in the inhibition of interleukin-5.

  Archives of pharmacal research 20070801

• Highly beta-selective O-glucosidation due to the restricted twist-boat conformation.

  Organic letters 20070412

• Structural requirement of chalcones for the inhibitory activity of interleukin-5.

  Bioorganic & medicinal chemistry 20070101

• The role of the hydrophobic group on ring A of chalcones in the inhibition of interleukin-5.

  Archives of pharmacal research 20061101

• Surface induced hydrogen-bonded macrocluster formation of methanol on silica surfaces.

  Langmuir : the ACS journal of surfaces and colloids 20051011

• Turbidity determination of the critical exponent eta in the liquid-liquid mixture methanol and cyclohexane.

  The Journal of chemical physics 20040322

• Glimepiride pharmacokinetics in obese versus non-obese diabetic patients.

  The Annals of pharmacotherapy 20040101

• Characterization of polychlorinated aromatic hydrocarbons by reversed-phase liquid chromatography with ultraviolet absorbance and mass spectrometric detection.

  Journal of chromatography. A 20031017

• What controls the thickness of wetting layers near bulk criticality?

  Physical review letters 20020826